iCAD, Inc. (ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, announced that more than 4,000 non-melanoma skin cancer (NMSC) patients have been treated using the Xoft® Axxent® Electronic Brachytherapy System® demonstrating continued growth and utilization of the system among radiation oncologists and dermatologists. In addition, a growing body of clinical evidence provides ongoing support for the use of the Xoft System for this skin cancer application. iCAD Inc (NASDAQ:ICAD) shares after opening at $8.20 moved to $8.75 on last trade day and at the end of the day closed at $8.51. Company price to sales ratio in past twelve months was calculated as 3.54 and price to cash ratio as 9.85. iCAD Inc (NASDAQ:ICAD) showed a positive weekly performance of 6.64%.
British pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) announced yesterday, April 13th, that the company is under investigation for bribery in Poland. The charges relate to efforts to promote GSK’s asthma drug Seretide. GlaxoSmithKline plc (ADR)(NYSE:GSK) shares fell -0.59% in last trading session and ended the day on $52.51. GSK return on equity ratio is recorded as 114.40% and its return on assets is 17.70%. GlaxoSmithKline plc (ADR)(NYSE:GSK) yearly performance is 9.19%.
Halliburton Company (NYSE:HAL) EVP Lawrence Pope sold 3,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $59.38, for a total transaction of $178,140.00. Following the completion of the transaction, the executive vice president now directly owns 161,937 shares in the company, valued at approximately $9,615,819. Halliburton Company (NYSE:HAL) shares moved up 0.66% in last trading session and was closed at $60.90, while trading in range of $ 60.08 – 61.46. Halliburton Company (NYSE:HAL) year to date (YTD) performance is 20.31%.
Kimberly-Clark Corp. (NYSE:KMB) will post its Q114 quarterly earnings results on Monday, April 21st. Analysts expect Kimberly-Clark Corp. to post earnings of $1.47 per share and revenue of $5.31 billion for the quarter. Kimberly-Clark Corp. has set its FY14 guidance at $6.00-6.20 EPS. Kimberly Clark Corp (NYSE:KMB) weekly performance is 1.32%. On last trading day company shares ended up $112.54. Kimberly Clark Corp (NYSE:KMB) distance from 50-day simple moving average (SMA50) is 2.98%. Analysts mean target price for the company is $108.00.